Abstract
Fluorescence intensity and lifetime imaging of NADH and FAD measure metabolic shifts in vivo at an early time-point after treatment with chemotherapy, a targeted inhibitor, and combination treatment in head and neck cancer xenografts.
© 2014 Optical Society of America
PDF Article | Presentation VideoMore Like This
Alex Walsh, Rebecca S. Cook, H. Charles Manning, Donna J. Hicks, Alec Lafontant, Carlos L. Arteaga, and Melissa C. Skala
MT3C.5 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2013
Melissa C. Skala, Alex J. Walsh, Amy T. Shah, Joseph T. Sharick, Tiffany M. Heaster, Rebecca S. Cook, Carlos L. Arteaga, Melinda E. Sanders, and Ingrid Meszoely
JW4A.1 Cancer Imaging and Therapy (Cancer) 2016
Marina V. Shirmanova, Maria M. Lukina, Lyubov’ E. Shimolina, Marina K. Kuimova, Varvara V. Dudenkova, Vladislav I. Shcheslavskiy, and Elena V. Zagaynova
1041102 European Conference on Biomedical Optics (ECBO) 2017